Science Corp raises $400 million, reaches $3.5 billion valuation

Science Corp raises $400 million, reaches $3.5 billion valuation
Science Corp raises $400M

Science Corp is expanding work on neurotechnology and blindness treatments after a fresh funding round lifted its valuation to $3.5 billion. The financing is set to support further development of a retinal implant for age-related blindness and brain-connected devices using engineered cells.

Highlights

  • Science Corp raised $400 million in a funding round, bringing its valuation to $3.5 billion including the new capital.
  • Proceeds will support development of implants for blindness and neural devices that connect to the brain using engineered cells.
  • Investors include Khosla Ventures, Tenet Healthcare Corp., and the Ackman Oxman Institute, reflecting strong interest in neurotechnology innovation.

Funding round backs retinal and brain-device development

As reported by Bloomberg, Science Corp said it raised $400 million in a recent fundraising round, with the valuation including the new capital. The company is using the proceeds to further develop implants designed to treat blindness and to build neural devices that connect to the brain through engineered cells.

Science Corp is known for a retinal chip that restores some vision to people with an age-related form of blindness. The latest financing adds to resources for advancing that device as well as broader neurotechnology programs.

Investor lineup highlights healthcare interest

Investors in the round include Khosla Ventures, Tenet Healthcare Corp., and the Ackman Oxman Institute. The institute is a brain research center established this year by hedge fund billionaire Bill Ackman and his wife, Neri Oxman.

The fundraising underscores continued investor interest in companies developing implant-based treatments and brain-interface technologies, a sector that sits at the intersection of medical devices, neuroscience, and healthcare innovation.

We have also analyzed Malaysian OGSE exports and financing under the National OGSE Industry Blueprint as another example of sector-backed funding and expansion.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.